Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;261(2):139-43.
doi: 10.1007/s00406-010-0116-z. Epub 2010 May 6.

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder

Affiliations

Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder

Izabela Guimarães Barbosa et al. Eur Arch Psychiatry Clin Neurosci. 2011 Mar.

Abstract

Bipolar disorder (BD) has been associated with a proinflammatory state in which TNF-α seems to play a relevant role. The aim of the present study was to evaluate the plasma levels of TNF-α and its soluble receptors (sTNFR1 and sTNFR2) in BD patients in mania and euthymia in comparison with control subjects. We evaluated 53 BD patients (34 in mania and 19 in euthymia) and 38 healthy subjects. All subjects were assessed by the Mini-International Neuropsychiatry Interview (MINI-Plus). Patients were also evaluated by the Young Mania Rating Scale (YMRS) and by Hamilton Depression Rating Scale (HDRS). Plasma TNF-α and its soluble receptors were measured by ELISA. The plasma TNF-α and sTNFR2 levels did not differ between groups, but higher sTNFR1 levels were found in BD patients. Of note, BD patients in mania had higher sTNFR1 levels than BD patients in euthymia and controls. The sTNFR1 and sTNFR2 levels correlated with BD duration, and sTNFR2 levels correlated with age of patients. Our data indicate a proinflammatory status in BD patients during mania and further suggest that inflammatory mechanisms may be involved with the physiopathology of BD.

PubMed Disclaimer

References

    1. J Neuroimmunol. 2009 Nov 30;216(1-2):122-5 - PubMed
    1. Acta Neurobiol Exp (Wars). 2008;68(4):526-34 - PubMed
    1. Clin Endocrinol (Oxf). 2007 Nov;67(5):784-9 - PubMed
    1. J Affect Disord. 2007 Dec;104(1-3):91-5 - PubMed
    1. J Clin Psychiatry. 2009 Aug;70(8):1078-90 - PubMed

Publication types

Substances